Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2007-11-30
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that increasing doses of mixed fiber will influence satiety response, food intake, glucose, insulin, ghrelin, GLP-1, and PYY 3-36, in a dose-dependent manner, when given to subjects in muffins for breakfast.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Post-prandial Glycemic Response to Fiber in Healthy Adults
NCT03252704
Effects of Dietary Fiber on Insulin Sensitivity
NCT01521806
Effect of Fiber on Glycemic Index
NCT02615327
Effects of a Dietary Fiber on Fecal Microbiota and Metabolism
NCT01518088
Fiber and Insulin Sensitivity
NCT04714944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
QUADRUPLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mixed Fiber Supplement
Breakfast Muffin containing 0g, 4g, 8g, and 12g of mixed fiber (total fiber amount as listed).
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy men and women
* 18 and 65 years of age
* non-smoking
* not taking medications
* non-dieting (weight stable over last 3 months)
* BMI between 18 and 27
* able to give blood through an IV
Exclusion Criteria
* food allergies to ingredients commonly found in muffins or pizza
* distaste for muffins or pizza
* BMI less than 18 or greater than 27
* weight change \> 5 kg in last 3 months (intentional or unintentional)
* cardiovascular disease
* diabetes mellitus (fasting blood sugar \> 126 mg/dl)
* cancer in prior 5 years (except basal cell carcinoma of skin)
* renal or hepatic disease
* Crohns disease
* ulcerative colitis
* any other gastrointestinal conditions that may affect digestion or absorption
* recent bacterial infection (\< 3 months)
* chronic medication use
* history of drug or alcohol abuse in prior 6 months
* concurrent or recent intervention study participation
* vegetarians
* people who ate more than approximately 15 g of fiber per day
* pregnant or lactating women
* women with irregular menstrual cycles
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Société des Produits Nestlé (SPN)
INDUSTRY
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joanne L Slavin, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota: General Clinical Research Center
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Willis HJ, Thomas W, Eldridge AL, Harkness L, Green H, Slavin JL. Glucose and insulin do not decrease in a dose-dependent manner after increasing doses of mixed fibers that are consumed in muffins for breakfast. Nutr Res. 2011 Jan;31(1):42-7. doi: 10.1016/j.nutres.2010.12.006.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0701M00265
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.